ATE540957T1 - Bicyclische peptidomimetikum-inhibitoren von aspartylproteasen zur behandlung von infektionskrankheiten - Google Patents
Bicyclische peptidomimetikum-inhibitoren von aspartylproteasen zur behandlung von infektionskrankheitenInfo
- Publication number
- ATE540957T1 ATE540957T1 AT08169901T AT08169901T ATE540957T1 AT E540957 T1 ATE540957 T1 AT E540957T1 AT 08169901 T AT08169901 T AT 08169901T AT 08169901 T AT08169901 T AT 08169901T AT E540957 T1 ATE540957 T1 AT E540957T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- peptidomimetics
- bicyclic
- inhibitors
- infectious diseases
- Prior art date
Links
- 102000004580 Aspartic Acid Proteases Human genes 0.000 title abstract 2
- 108010017640 Aspartic Acid Proteases Proteins 0.000 title abstract 2
- 208000035473 Communicable disease Diseases 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000816 peptidomimetic Substances 0.000 title 1
- CJQNJRRDTPULTL-UHFFFAOYSA-N 3-azabicyclo[3.2.1]octane Chemical class C1C2CCC1CNC2 CJQNJRRDTPULTL-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08169901A EP2189462B9 (de) | 2008-11-25 | 2008-11-25 | Bicyclische Peptidomimetikum-Inhibitoren von Aspartylproteasen zur Behandlung von Infektionskrankheiten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE540957T1 true ATE540957T1 (de) | 2012-01-15 |
Family
ID=40383580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08169901T ATE540957T1 (de) | 2008-11-25 | 2008-11-25 | Bicyclische peptidomimetikum-inhibitoren von aspartylproteasen zur behandlung von infektionskrankheiten |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8445484B2 (de) |
| EP (1) | EP2189462B9 (de) |
| JP (1) | JP5660633B2 (de) |
| CN (1) | CN102224159A (de) |
| AT (1) | ATE540957T1 (de) |
| ES (1) | ES2380613T3 (de) |
| WO (1) | WO2010060904A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITFI20120062A1 (it) * | 2012-03-21 | 2013-09-22 | Minerva Patents S A | Componenti per il trattamento di malattie correlate a ischemia-riperfusione. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITFI20020107A1 (it) | 2002-06-19 | 2003-12-19 | Antonio Guarna | Composizioni farmaceutiche atte all'uso nel trattamento di patologie correlate all'azione di neutrofine e composti attivi in esse contenuti |
| CA2521938A1 (en) * | 2003-04-30 | 2004-11-11 | Actelion Pharmaceuticals Ltd | 9-azabicyclo[3.3.1]non-6-ene derivatives with a heteroatom at the 3-position as renin inhibitors |
-
2008
- 2008-11-25 AT AT08169901T patent/ATE540957T1/de active
- 2008-11-25 EP EP08169901A patent/EP2189462B9/de not_active Not-in-force
- 2008-11-25 ES ES08169901T patent/ES2380613T3/es active Active
-
2009
- 2009-11-24 CN CN200980147438XA patent/CN102224159A/zh active Pending
- 2009-11-24 JP JP2011536898A patent/JP5660633B2/ja not_active Expired - Fee Related
- 2009-11-24 WO PCT/EP2009/065728 patent/WO2010060904A1/en not_active Ceased
- 2009-11-24 US US13/130,666 patent/US8445484B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2380613T9 (es) | 2013-03-25 |
| ES2380613T3 (es) | 2012-05-16 |
| EP2189462A1 (de) | 2010-05-26 |
| US8445484B2 (en) | 2013-05-21 |
| EP2189462B1 (de) | 2012-01-11 |
| WO2010060904A1 (en) | 2010-06-03 |
| JP5660633B2 (ja) | 2015-01-28 |
| CN102224159A (zh) | 2011-10-19 |
| EP2189462B9 (de) | 2012-06-13 |
| JP2012509863A (ja) | 2012-04-26 |
| US20110237577A1 (en) | 2011-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE506951T1 (de) | Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit | |
| EA201100119A1 (ru) | Химические соединения 251 | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| EA201170508A1 (ru) | Производные 1-амино-2-циклобутилэтилбороновой кислоты | |
| MY148851A (en) | Dihydropyridine derivatives as useful as protein kinase inhibitors | |
| EA201170963A1 (ru) | Ингибиторы поли(адф-рибозо)полимеразы (parp) | |
| AU2011338389A8 (en) | Bicyclic compounds as Pim inhibitors | |
| UA110612C2 (uk) | Похідні 1-аміно-2-циклопропілетилборонової кислоти | |
| NO20084652L (no) | Deazapuriner anvendelige som inhibitorer av januskinaser | |
| EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
| EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
| TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
| MY161991A (en) | Proteasome inhibitors | |
| MY155649A (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
| UA103321C2 (ru) | Производные тиенопиридона как активаторы amp-активированной протеинкиназы (амрк) | |
| BR112012018386A8 (pt) | "inibidores isoindolinona de fosfatidilinositol 3-quinase" | |
| EA200602062A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
| PH12013502262A1 (en) | Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors | |
| ATE419859T1 (de) | Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut | |
| EP2135858A4 (de) | Zusammensetzung zur behandlung von infektionserkrankungen | |
| MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
| EA201000329A1 (ru) | Циклические депсипептиды | |
| MX2009006170A (es) | Compuestos y composiciones como inhibidores de cinasa. | |
| PH12012502070A1 (en) | Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders | |
| ATE517873T1 (de) | 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten |